- Home
- ORRF vs EBS Comparison
ORRF vs EBS Comparison
Compare ORRF & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ORRF | EBS |
|---|---|---|
| Founded | 1919 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 737.4M | 663.3M |
| IPO Year | N/A | 2006 |
Fundamental Metrics
Financial Performance| Metric | ORRF | EBS |
|---|---|---|
| Price | $34.91 | $12.55 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $42.00 | $15.00 |
| AVG Volume (30 Days) | 324.6K | ★ 798.1K |
| Earning Date | 01-30-2026 | 10-29-2025 |
| Dividend Yield | ★ 3.09% | N/A |
| EPS Growth | ★ 198.98 | N/A |
| EPS | ★ 3.78 | 1.35 |
| Revenue | $247,296,000.00 | ★ $788,900,000.00 |
| Revenue This Year | $26.82 | N/A |
| Revenue Next Year | $2.18 | $15.21 |
| P/E Ratio | ★ $9.23 | $9.26 |
| Revenue Growth | ★ 66.90 | N/A |
| 52 Week Low | $25.57 | $4.02 |
| 52 Week High | $38.38 | $13.41 |
Technical Indicators
Market Signals| Indicator | ORRF | EBS |
|---|---|---|
| Relative Strength Index (RSI) | 35.58 | 60.71 |
| Support Level | $35.92 | $12.02 |
| Resistance Level | $37.99 | $12.90 |
| Average True Range (ATR) | 0.65 | 0.51 |
| MACD | -0.35 | -0.05 |
| Stochastic Oscillator | 0.72 | 73.60 |
Price Performance
Historical ComparisonAbout ORRF Orrstown Financial Services Inc
Orrstown Financial Services Inc is a holding company engaged in commercial banking and trust business, this involves accepting demand, time, and savings deposits and granting loans. The company is also engaged in lending services for commercial, residential, commercial mortgages, construction, municipal, and various forms of consumer lending, and deposit services that include checking, savings, time, and money market deposits. It also provides investment and brokerage services through its Financial Advisors division. The Company earns fees from its deposit clients for transaction-based account maintenance and overdraft services, It also earns wealth management and investment brokerage fees from its contracts with trusts. The company operates in a segment, namely Community Banking.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.